Two Sigma Investments
CUE icon

Two Sigma Investments’s Cue Biopharma CUE Stock Holding History

Two Sigma Investments’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-666
Closed -$37.8K – 3083
2024
Q1 		$37.8K Buy
+666
New +$47K ﹤0.01% 2896
2023
Q3 		– Sell
-469
Closed -$51.4K – 2992
2023
Q2 		$51.4K Buy
+469
New +$55.1K ﹤0.01% 2826
2022
Q4 		– Sell
-1,137
Closed -$76K – 2844
2022
Q3 		$76K Sell
1,137
-3,225
-74% -$277K ﹤0.01% 2265
2022
Q2 		$326K Sell
4,362
-1,530
-26% -$179K ﹤0.01% 1998
2022
Q1 		$863K Buy
5,892
+4,034
+217% +$855K ﹤0.01% 1770
2021
Q4 		$631K Sell
1,858
-1,590
-46% -$615K ﹤0.01% 3019
2021
Q3 		$1.51M Sell
3,448
-3,248
-49% -$1.13M ﹤0.01% 2239
2021
Q2 		$2.34M Sell
6,696
-4,103
-38% -$1.59M 0.01% 1741
2021
Q1 		$3.95M Sell
10,799
-34
-0.3% -$14K 0.01% 1213
2020
Q4 		$4.07M Buy
10,833
+839
+8% +$335K 0.01% 1051
2020
Q3 		$4.51M Buy
9,994
+2,212
+28% +$1.27M 0.02% 841
2020
Q2 		$5.72M Buy
+7,782
New +$5.64M 0.03% 597

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GLA
Good Life Advisors Reading, Pennsylvania $1.6B AUM 15.83% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Two Sigma Investments's CUE Position: Q2 2024 in Review

Two Sigma Investments sold out of Cue Biopharma (CUE) in Q2 2024, closing a stake of 666 shares — an estimated $37.8K sold.

Two Sigma Investments first reported a position in CUE in Q2 2020 and held it in 12 quarters. The position peaked at $5.72M in Q2 2020. 75 funds tracked by Wall St. Rank hold CUE as of Q2 2024.

  • Two Sigma Investments reported no remaining Cue Biopharma position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Investments sold 666 Cue Biopharma shares in Q2 2024, an estimated $37.8K.
  • Two Sigma Investments first reported a position in Cue Biopharma in Q2 2020 and held it in 12 quarters.
  • Two Sigma Investments's Cue Biopharma position peaked at $5.72M in Q2 2020.
  • 75 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2024.

Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.